tiprankstipranks
China Medical System Holdings Ltd. (HK:0867)
:0867
Hong Kong Market
0867
China Medical System Holdings
RESEARCH TOOLSreports

China Medical System Holdings (0867) Ratios

3 Followers

China Medical System Holdings Ratios

HK:0867's free cash flow for Q4 2025 was ¥0.71. For the 2025 fiscal year, HK:0867's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.33 6.33 5.74 4.29 3.07
Quick Ratio
 5.78 5.78 5.24 3.98 2.90
Cash Ratio
 1.84 1.84 2.44 2.10 1.52
Solvency Ratio
 1.04 1.03 1.14 1.20 1.15
Operating Cash Flow Ratio
 0.52 0.52 0.84 1.22 1.24
Short-Term Operating Cash Flow Coverage
 1.13 1.13 1.53 1.97 1.99
Net Current Asset Value
¥ 7.65B¥ 7.65B¥ 7.06B¥ 6.62B¥ 5.81B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.05 0.07 0.10
Debt-to-Equity Ratio
 0.04 0.04 0.05 0.08 0.12
Debt-to-Capital Ratio
 0.04 0.04 0.05 0.08 0.11
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.10 1.11 1.14 1.22
Debt Service Coverage Ratio
 1.71 1.68 2.20 1.85 1.79
Interest Coverage Ratio
 176.57 77.77 44.87 58.65 72.37
Debt to Market Cap
 0.02 0.02 0.05 0.04 0.07
Interest Debt Per Share
 0.29 0.29 0.37 0.55 0.76
Net Debt to EBITDA
 -1.11 -1.12 -1.23 -1.03 -0.68
Profitability Margins
Gross Profit Margin
71.51%71.50%72.60%75.82%76.89%
EBIT Margin
19.23%19.22%27.43%33.85%38.82%
EBITDA Margin
22.28%22.47%30.90%36.47%41.11%
Operating Profit Margin
19.23%19.22%23.20%33.85%38.82%
Pretax Profit Margin
25.63%25.61%26.92%35.86%41.12%
Net Profit Margin
18.17%18.13%21.69%29.96%35.62%
Continuous Operations Profit Margin
17.62%17.58%21.60%29.76%35.80%
Net Income Per EBT
70.90%70.80%80.57%83.55%86.61%
EBT Per EBIT
133.27%133.23%116.03%105.93%105.92%
Return on Assets (ROA)
7.70%7.55%8.97%13.54%18.36%
Return on Equity (ROE)
8.60%8.33%9.93%15.47%22.34%
Return on Capital Employed (ROCE)
8.83%8.67%10.48%17.30%23.88%
Return on Invested Capital (ROIC)
5.85%5.73%8.00%13.27%18.55%
Return on Tangible Assets
10.57%10.36%12.45%17.19%25.59%
Earnings Yield
4.86%5.17%9.41%7.92%12.25%
Efficiency Ratios
Receivables Turnover
 3.33 3.27 4.02 4.62 4.49
Payables Turnover
 21.76 21.38 14.37 13.68 11.88
Inventory Turnover
 2.88 2.83 2.66 3.04 4.43
Fixed Asset Turnover
 18.24 17.92 16.67 16.91 18.47
Asset Turnover
 0.42 0.42 0.41 0.45 0.52
Working Capital Turnover Ratio
 1.05 1.07 1.07 1.26 1.63
Cash Conversion Cycle
 219.52 223.40 202.47 172.51 133.01
Days of Sales Outstanding
 109.75 111.70 90.89 79.07 81.36
Days of Inventory Outstanding
 126.54 128.76 136.98 120.13 82.37
Days of Payables Outstanding
 16.77 17.07 25.40 26.69 30.73
Operating Cycle
 236.29 240.47 227.87 199.20 163.74
Cash Flow Ratios
Operating Cash Flow Per Share
 0.31 0.31 0.52 1.02 1.45
Free Cash Flow Per Share
 0.10 0.10 0.33 0.89 1.23
CapEx Per Share
 0.21 0.21 0.19 0.13 0.21
Free Cash Flow to Operating Cash Flow
 0.32 0.32 0.64 0.87 0.85
Dividend Paid and CapEx Coverage Ratio
 0.65 0.65 1.25 1.49 1.97
Capital Expenditure Coverage Ratio
 1.47 1.47 2.78 7.87 6.77
Operating Cash Flow Coverage Ratio
 1.10 1.10 1.47 1.92 1.96
Operating Cash Flow to Sales Ratio
 0.09 0.09 0.17 0.31 0.39
Free Cash Flow Yield
0.80%0.87%4.72%7.21%11.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.58 19.33 10.63 12.62 8.16
Price-to-Sales (P/S) Ratio
 3.77 3.50 2.30 3.78 2.91
Price-to-Book (P/B) Ratio
 1.75 1.61 1.06 1.95 1.82
Price-to-Free Cash Flow (P/FCF) Ratio
 125.73 114.89 21.18 13.87 8.79
Price-to-Operating Cash Flow Ratio
 40.15 36.96 13.57 12.11 7.49
Price-to-Earnings Growth (PEG) Ratio
 -2.00 -1.85 -0.34 -0.48 0.91
Price-to-Fair Value
 1.75 1.61 1.06 1.95 1.82
Enterprise Value Multiple
 15.80 14.48 6.22 9.34 6.39
Enterprise Value
 28.67B 26.02B 14.37B 27.30B 24.04B
EV to EBITDA
 15.80 14.48 6.22 9.34 6.39
EV to Sales
 3.52 3.25 1.92 3.41 2.63
EV to Free Cash Flow
 117.50 106.64 17.68 12.49 7.94
EV to Operating Cash Flow
 37.80 34.31 11.33 10.91 6.77
Tangible Book Value Per Share
 5.10 5.10 4.68 4.81 3.96
Shareholders’ Equity Per Share
 7.19 7.19 6.72 6.33 5.95
Tax and Other Ratios
Effective Tax Rate
 0.31 0.31 0.20 0.17 0.13
Revenue Per Share
 3.36 3.31 3.08 3.27 3.73
Net Income Per Share
 0.61 0.60 0.67 0.98 1.33
Tax Burden
 0.71 0.71 0.81 0.84 0.87
Interest Burden
 1.33 1.33 0.98 1.06 1.06
Research & Development to Revenue
 0.07 0.07 0.04 0.02 0.01
SG&A to Revenue
 0.45 0.45 0.46 0.08 0.07
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.00 >-0.01 <0.01
Income Quality
 0.36 0.36 0.63 0.87 0.94
Currency in CNY